|Nome||Titolo||Retribuzione||Esercitate||Anno di nascita|
|Ms. Kari Eian Krogstad||CEO & Pres||3,27M||N/D||1964|
|Mr. Thomas Jakobsen||Chief Financial Officer||2M||N/D||1969|
|Mr. Helge Borslid||VP of Operations & Manufacturing||1,43M||N/D||N/D|
|Ms. Hæge Johanne Krogh Wetterhus||VP of Marketing||1,49M||N/D||1964|
|Mr. Roger Reino Morberg||VP of Sales||1,71M||N/D||1964|
|Mr. Hakon Grothe||Chief Innovation Officer||1,41M||N/D||N/D|
|Mr. Ole Jorgen Robsrud||CEO of Medistim Norge AS & MD of Medistim Norge AS||1,4M||N/D||N/D|
|Mr. Mike Farbelow||Pres of Medistim USA Inc||2,86M||N/D||N/D|
|Cindy Kaffai||Country Mang. of Medistim Deutschland GmbH||1,68M||N/D||N/D|
|Mr. Ole Arne Eiksund||Chief Bus. Devel. Officer||N/D||N/D||1967|
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.
L'ISS Governance QualityScore di Medistim ASA al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.